It was showed that Ki-67 (P=0.039), therapy cycle (P<0.001), CEA (P=0.025) and SII (P=0.019) were independent predictors of pCR after neoadjuvant chemotherapy in breast cancer patients (Table 3). Here, CEACAM5 is linked to breast carcinoma.